ReviewCancers2022
CC Chemokine Ligand-2: A Promising Target for Overcoming Anticancer Drug Resistance.
Zhenbo Shi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
ReviewCancers2022
Zhenbo Shi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.